Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. Patients. We discover, develop and manufacture innovative medicines to help millions of patients. Amgen helped establish the biotechnology industry more than 45 years ago and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.

Present in France since 1990, Amgen employs more than 360 people here with 20% dedicated to R&D. With approximately 20 medicines, Amgen France strives to advance the management of cancer, cardiovascular, inflammatory, kidney, and rare diseases.